Log in

NASDAQ:OYSTOyster Point Pharma Stock Price, Forecast & News

$25.22
+0.06 (+0.24 %)
(As of 08/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$24.64
Now: $25.22
$25.85
50-Day Range
$22.37
MA: $25.80
$29.18
52-Week Range
$13.26
Now: $25.22
$41.37
Volume42,027 shs
Average Volume104,526 shs
Market Capitalization$649.49 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Oyster Point Pharma, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ocular surface diseases in the United States. It is involved in developing OC-01, a nicotinic acetylcholine receptor agonist that is in Phase IIb clinical trial to treat the signs and symptoms of dry eye disease, as well as Phase III clinical trial for the neurotrophic keratitis. The company was founded in 2018 and is headquartered in Princeton, New Jersey.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.58 out of 5 stars


Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:OYST
CUSIPN/A
CIKN/A
Phone609-382-9032

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$6.43 per share

Profitability

Net Income$-45,710,000.00

Miscellaneous

Employees18
Market Cap$649.49 million
Next Earnings Date12/1/2020 (Estimated)
OptionableNot Optionable
$25.22
+0.06 (+0.24 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OYST News and Ratings via Email

Sign-up to receive the latest news and ratings for OYST and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Oyster Point Pharma (NASDAQ:OYST) Frequently Asked Questions

How has Oyster Point Pharma's stock price been impacted by Coronavirus?

Oyster Point Pharma's stock was trading at $31.31 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OYST shares have decreased by 19.5% and is now trading at $25.22.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Oyster Point Pharma?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oyster Point Pharma in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Oyster Point Pharma
.

When is Oyster Point Pharma's next earnings date?

Oyster Point Pharma is scheduled to release its next quarterly earnings announcement on Tuesday, December 1st 2020.
View our earnings forecast for Oyster Point Pharma
.

How were Oyster Point Pharma's earnings last quarter?

Oyster Point Pharma (NASDAQ:OYST) announced its earnings results on Wednesday, August, 5th. The company reported ($0.66) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.81) by $0.15.
View Oyster Point Pharma's earnings history
.

What price target have analysts set for OYST?

3 analysts have issued 12 month price targets for Oyster Point Pharma's stock. Their forecasts range from $35.00 to $60.00. On average, they anticipate Oyster Point Pharma's stock price to reach $46.25 in the next year. This suggests a possible upside of 83.4% from the stock's current price.
View analysts' price targets for Oyster Point Pharma
.

Has Oyster Point Pharma been receiving favorable news coverage?

Media coverage about OYST stock has been trending positive recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Oyster Point Pharma earned a coverage optimism score of 2.4 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days.
View the latest news about Oyster Point Pharma
.

Are investors shorting Oyster Point Pharma?

Oyster Point Pharma saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 644,200 shares, an increase of 63.1% from the June 15th total of 395,000 shares. Based on an average trading volume of 140,200 shares, the short-interest ratio is presently 4.6 days. Approximately 8.9% of the shares of the stock are sold short.
View Oyster Point Pharma's Short Interest
.

Who are some of Oyster Point Pharma's key competitors?

What other stocks do shareholders of Oyster Point Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oyster Point Pharma investors own include Walt Disney (DIS), Fulcrum Therapeutics (FULC), Energy Transfer LP Unit (ET), NGM Biopharmaceuticals (NGM), NVIDIA (NVDA), Opko Health (OPK), Occidental Petroleum (OXY), AbbVie (ABBV), Alibaba Group (BABA) and Johnson & Johnson (JNJ).

Who are Oyster Point Pharma's key executives?

Oyster Point Pharma's management team includes the following people:
  • Dr. Jeffrey Nau Ph.D., MMS, Pres, CEO & Director (Age 44)
  • Mr. Daniel Lochner, Chief Financial Officer (Age 37)
  • Ms. Dawn Pruitt Koffler M.B.A., VP of Marketing
  • Mr. John Snisarenko, Chief Commercial Officer (Age 56)

When did Oyster Point Pharma IPO?

(OYST) raised $85 million in an IPO on Thursday, October 31st 2019. The company issued 5,000,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, Cowen and Piper Jaffray served as the underwriters for the IPO.

What is Oyster Point Pharma's stock symbol?

Oyster Point Pharma trades on the NASDAQ under the ticker symbol "OYST."

Who are Oyster Point Pharma's major shareholders?

Oyster Point Pharma's stock is owned by a variety of retail and institutional investors. Top institutional investors include RTW Investments LP (7.41%), Emerald Mutual Fund Advisers Trust (1.39%), Emerald Advisers LLC (1.33%), Great Point Partners LLC (0.83%), GW&K Investment Management LLC (0.73%) and Oak Ridge Investments LLC (0.46%). Company insiders that own Oyster Point Pharma stock include Clare Ozawa, Daniel Lochner, Healthcare Strategic Growt Kkr, Jeffrey Nau, John Snisarenko and Vida Ventures, Llc.
View institutional ownership trends for Oyster Point Pharma
.

Which major investors are selling Oyster Point Pharma stock?

OYST stock was sold by a variety of institutional investors in the last quarter, including Board of Trustees of The Leland Stanford Junior University, MCF Advisors LLC, Alps Advisors Inc., and Bank of New York Mellon Corp.
View insider buying and selling activity for Oyster Point Pharma
.

Which major investors are buying Oyster Point Pharma stock?

OYST stock was purchased by a variety of institutional investors in the last quarter, including RTW Investments LP, Great Point Partners LLC, GW&K Investment Management LLC, Emerald Mutual Fund Advisers Trust, Oak Ridge Investments LLC, Alyeska Investment Group L.P., Emerald Advisers LLC, and Goldman Sachs Group Inc.. Company insiders that have bought Oyster Point Pharma stock in the last two years include Clare Ozawa, Daniel Lochner, Healthcare Strategic Growt Kkr, Jeffrey Nau, John Snisarenko, and Vida Ventures, Llc.
View insider buying and selling activity for Oyster Point Pharma
.

How do I buy shares of Oyster Point Pharma?

Shares of OYST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Oyster Point Pharma's stock price today?

One share of OYST stock can currently be purchased for approximately $25.22.

How big of a company is Oyster Point Pharma?

Oyster Point Pharma has a market capitalization of $649.49 million. The company earns $-45,710,000.00 in net income (profit) each year or ($9.97) on an earnings per share basis. Oyster Point Pharma employs 18 workers across the globe.

What is Oyster Point Pharma's official website?

The official website for Oyster Point Pharma is www.oysterpointrx.com.

How can I contact Oyster Point Pharma?

Oyster Point Pharma's mailing address is 202 CARNEGIE CENTER SUITE 109, PRINCETON NJ, 08540. The company can be reached via phone at 609-382-9032 or via email at [email protected]

This page was last updated on 8/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.